Publications by Matthew D. Reed

< back to bio

FTC Releases Second Interim Staff Report on Pharmacy Benefit Managers

[01/29/25]

Pressure on PBMs Intensifies as FTC Targets Top PBMs Over Insulin Rebates

[09/30/24]

No Surprises Act IDR Extension

[07/08/24]

CMS Requests Information about Medicare Advantage Data

[03/08/24]

Federal Government Finalizes 2024 No Surprises Act IDR Fees

[01/16/24]

Federal Departments Update No Surprises Act IDR Process Again

[11/17/23]

Proposed Rule Sets New IDR Fees in Response to Federal Court Ruling

[10/05/23]

Federal Court Strikes Down Seven-Fold IDR Fee Increase: The Texas Medical Association Again Defeats HHS in Court

[08/28/23]

Proposed CMS Rule Targets PBM Price Transparency for Medicaid Managed Care Organizations

[06/23/23]

No Surprises Act Enforcement Begins

[02/20/23]

CMS Publishes RADV Audit Methodology and Intent to Recover Overpayments

[02/14/23]

CMS Delays Looming Good Faith Estimate Co-Provider Requirement

[12/05/22]

Déjà Vu – Texas Medical Association Challenges No Surprises Act Again

[11/03/22]

Quoted in "Tensions boil between ER docs, insurers as no-surprises law rolls out," IBJ (September 2022)

[09/16/2022]

Federal Surprise Billing Round 3 – Clarifying the QPA and IDR Process

[08/31/22]

Reminder: Transparency in Coverage Rule Takes Effect July 1, 2022

[07/01/22]

FTC Launches Inquiry into Pharmacy Benefit Managers: Is This Time Different?

[06/15/22]

Federal Court Strikes Down Qualifying Payment Amount Presumption Under No Surprises Act Dispute Resolution Process

[02/25/22]

CMS Releases Guidance on No Surprises Act Implementation

[01/25/22]

"Federal Surprise Billing Regulations Round 2," AHLA (December 2021).

[12/22/2021]

AHA & AMA Sue Over No Surprises Act Dispute Resolution Process

[12/10/21]

Federal Surprise Billing Round 2 – The IDR Process

[11/02/21]

Temporary Relief: Federal Government Defers Enforcement of Certain Transparency and Disclosure Requirements Under the No Surprises Act

[09/10/21]

Webinar Q&A: Surprise Billing and Price Transparency Update

[08/23/21]

Federal Surprise Billing Rules: The First Round Arrives

[07/26/21]

Indiana’s New Advance Directives Law

[07/01/21]

Federal Appeals Court Upholds Hospital Price Transparency Rule

[12/30/20]

Open the Floodgates: U.S. Supreme Court Decides ERISA Does Not Preempt Arkansas State Law Regulating PBMs

[12/23/20]

OIG Finalizes Controversial Rule Updating AKS Discount Safe Harbor Applicable to Prescription Drug Rebates

[12/21/20]

Pulling Back the Curtain: Final Rule Requires Payors to Disclose Rates

[12/02/20]

Pharmacists’ Expanded Authority to Administer Childhood Vaccines: What to Know

[10/06/20]